S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
This healthcare stock making a buzz with 160% growth
First it was Tyson stock, now this food company is set to rally
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
How major US stock indexes fared Monday, 2/26/2024
This infrastructure construction stock: Is it ready to pop?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Is Roku worth a second look after the earnings panic selloff?
Is The Trade Desk signaling the rebound of digital advertising?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
This healthcare stock making a buzz with 160% growth
First it was Tyson stock, now this food company is set to rally
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
How major US stock indexes fared Monday, 2/26/2024
This infrastructure construction stock: Is it ready to pop?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Is Roku worth a second look after the earnings panic selloff?
Is The Trade Desk signaling the rebound of digital advertising?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
This healthcare stock making a buzz with 160% growth
First it was Tyson stock, now this food company is set to rally
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
How major US stock indexes fared Monday, 2/26/2024
This infrastructure construction stock: Is it ready to pop?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Is Roku worth a second look after the earnings panic selloff?
Is The Trade Desk signaling the rebound of digital advertising?
S&P 500   5,069.53
DOW   39,069.23
QQQ   436.55
These 2 carnivore dining stocks gaining on the Ozempic craze
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
This healthcare stock making a buzz with 160% growth
First it was Tyson stock, now this food company is set to rally
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
How major US stock indexes fared Monday, 2/26/2024
This infrastructure construction stock: Is it ready to pop?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Is Roku worth a second look after the earnings panic selloff?
Is The Trade Desk signaling the rebound of digital advertising?

Adverum Biotechnologies (ADVM) Earnings Date, Estimates & Call Transcripts

$1.95
-0.05 (-2.50%)
(As of 02/26/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

ADVM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ADVM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Adverum Biotechnologies Analyst EPS Estimates

Current Year EPS Consensus Estimate:($1.26) EPS
Next Year EPS Consensus Estimate: ($0.87) EPS

ADVM Earnings Date and Information

Adverum Biotechnologies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based off prior year's report dates.

Adverum Biotechnologies Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/4/2024
Estimated)
------- 
11/9/2023Q3 2023($0.30)($0.33)($0.03)($0.33)--
8/10/2023Q2 2023($0.32)($0.31)+$0.01($0.31)--
5/11/2023Q1 2023($0.30)($0.29)+$0.01($0.29)-$3.60 million
3/30/2023Q4 2022($0.32)($0.33)($0.01)($0.33)--
11/10/2022Q3 2022($0.32)($0.40)($0.08)($0.40)--
8/11/2022Q2 2022($0.38)($0.44)($0.06)($0.44)--
5/12/2022Q1 2022($0.34)($0.38)($0.04)($0.38)--    
3/29/2022Q4 2021($0.42)($0.35)+$0.07($0.35)--
11/4/2021Q3 2021($0.38)($0.39)($0.01)($0.39)--
8/4/2021Q2 2021($0.38)($0.45)($0.07)($0.45)--
5/5/2021Q1 2021($0.38)($0.29)+$0.09($0.29)$0.46 million$7.50 million
2/28/2021Q4 2020($0.32)($0.39)($0.07)($0.39)--  












Adverum Biotechnologies Earnings - Frequently Asked Questions

When is Adverum Biotechnologies's earnings date?

Adverum Biotechnologies has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based off last year's report dates. Learn more on ADVM's earnings history.

How much revenue does Adverum Biotechnologies generate each year?

Adverum Biotechnologies (NASDAQ:ADVM) has a recorded annual revenue of $7.50 million.

How much profit does Adverum Biotechnologies generate each year?

Adverum Biotechnologies (NASDAQ:ADVM) has a recorded net income of -$154.54 million. ADVM has generated -$1.26 earnings per share over the last four quarters.

What is Adverum Biotechnologies's EPS forecast for next year?

Adverum Biotechnologies's earnings are expected to grow from ($1.26) per share to ($0.87) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ADVM) was last updated on 2/27/2024 by MarketBeat.com Staff